
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:title xml:lang="srp">Karakterizacija i ispitivanje antitumorske aktivnosti kompleksa cinka (II) sa S-alkenil derivatima tiosalicilne kiseline</dc:title>
  <dc:creator>Popović,  Ana M., 1979-, 62355209</dc:creator>
  <dc:description xml:lang="srp">Dva kompleksa cinka(II) i S-alkenil derivata tiosalicilne kiseline (engl. S-alkenyl derivatives of thiosalicylic acid- SADTA) (ligandi) su sintetisani i karakterisani na osnovu rezultata elementalne mikroanalize, IR,
1H i 13C NMR spektroskopije. Kompleksi su dobijeni direktnom reakcijom ZnCl2 i SADTA, u vodenom rastvoru. Prema fizičkohemijskim i spektroskopskim podacima, zaključujemo da su ligandi bidentatno
koordinovani za jon cinka(II). Interakcija kompleksa sa DNA goveđeg timusa (CT-DNA)
ispitivana je Uv-vis i fluorimetrijskom metodom. Citotoksična aktivnost kompleksa
poređena je sa oksaliplatinom i cisplatinom i analizirana je na dvije različite
tumorske ćelijske linije: mišji karcinom debelog crijeva (CT26) i mišji melanom
(B16F1), dok su ne-tumorske mišje mezenhimske matične ćelije (mmMSCs) korišćene kao
kontrola. Oba kompleksa pokazala su umjerenu aktivnost protiv ćelija mišjeg raka
debelog crijeva i melanoma. Smanjenje vijabilnosti ćelija melanoma je izazvano
zadržavanjem ćelije u G2 fazi ćelijskog ciklusa i apoptozom. Cink(II) kompleks sa
SADTA, iako ima značajno slabiji citotoksični efekat na tumorske ćelije nego
oksaliplatina i cisplatina, djeluje selektivnije na tumorske ćelije od poznatih ljekova.</dc:description>
  <dc:description xml:lang="eng">In this study, we generated and analized two complexes of zinc (II) and S-alkenyl derivatives of thiosalicylic acid- SADTА (ligands), by microanalysis, IR, H and C NMR spectroscopy.
Synthesis of the complexes was accomplished by direct contact of ZnCl2 and SADTА. Physicochemical as well as spectroscopic analysis revealed bidentately coordination of the ligands to the zinc(II) center. Absorption as well as ethidium bromide displacement analyses were used for CTDNA test. Citotoxicity of the complexes was tested in colon carcinoma (CT26) and melanoma
(B16F1), as well as in mesenchymal stem cells (mMSCs), all derived from mouse. Citotoxicity of complexes was compared with oxaliplatin and cisplatin.
We revealed moderate citotoxicity of complexes against tumor cells. This phenomenon was acompained by induction of apoptosis and G2 phase arrest. The tested zinc (II) complexes has a
weaker cytotoxicity than oxaliplatin and cisplatin. However, they show a much more selective
effect on tumors than known drugs.</dc:description>
  <dc:description xml:lang="srp"></dc:description>
  <dc:contributor>Jovanović,  Ivan, 1977-, 3999847</dc:contributor>
  <dc:contributor>Milovanović,  Marija, 1979-, 6451047</dc:contributor>
  <dc:contributor>Radić,  Gordana, 1980-, 25784423</dc:contributor>
  <dc:contributor>Vojvodić,  Danilo, 1963-, 10764647</dc:contributor>
  <dc:date>2020</dc:date>
  <dc:date>2020</dc:date>
  <dc:date>2020</dc:date>
  <dc:date>2020</dc:date>
  <dc:date>2020</dc:date>
  <dc:date>2020</dc:date>
  <dc:type xml:lang="eng">baccalaureate Dissertation</dc:type>
  <dc:format>76 listova</dc:format>
  <dc:format>2313152 bytes</dc:format>
  <dc:identifier>o:1305</dc:identifier>
  <dc:identifier>ID=28560905 ; D-3389</dc:identifier>
  <dc:identifier>thesis:7831</dc:identifier>
  <dc:identifier>cobiss:28560905</dc:identifier>
  <dc:identifier>https://phaidrakg.kg.ac.rs/o:1305</dc:identifier>
  <dc:source>Thesis:7831</dc:source>
  <dc:source>Cobiss:28560905</dc:source>
  <dc:language>srp</dc:language>
  <dc:rights>CC BY-ND 2.0 AT</dc:rights>
  <dc:rights>http://creativecommons.org/licenses/by-nd/2.0/at/</dc:rights>
</oai_dc:dc>
